<DOC>
	<DOCNO>NCT01757379</DOCNO>
	<brief_summary>The purpose study evaluate bioavailability acetate , propionate butyrate healthy human use stable isotope technology . In addition level acetate , propionate butyrate production inulin determine use principle isotope dilution .</brief_summary>
	<brief_title>Determination Bioavailability Short Chain Fatty Acids Healthy Humans</brief_title>
	<detailed_description />
	<mesh_term>Butyric Acid</mesh_term>
	<criteria>Healthy volunteer Regular dietary pattern ( 3 meals/day ) Age : 1865y BMI : 18,527 kg/m2 Intake antibiotic 1 month prior study Abdominal surgery past , exception appendectomy Intake medication influence gastrointestinal system 14 day prior study In treatment dietician Intake pre and/or probiotic Exposure radioactivity 1 year prior study Serious chronic disease gastrointestinal tract Use medication affect gastrointestinal tract last 2 week prior study Pregnancy , pregnancy desire lactation Blood donation last 3 month prior study Diabetes ( type 1 2 ) Aberrant hemoglobin level ( Hb ) blood . Normal 14.0 18.0 g/dL men 12.0 16.0 g/dL woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Short chain fatty acid</keyword>
	<keyword>Acetate</keyword>
	<keyword>Propionate</keyword>
	<keyword>Butyrate</keyword>
	<keyword>Bioavailability</keyword>
</DOC>